Kodi-M Co Ltd Total Liabilities
Kodi-M Co Ltd total liabilities. Based on the latest financial reports, Kodi-M Co Ltd (224060) has total liabilities worth ₩69.73 Billion KRW (≈ $47.25 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 224060 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Kodi-M Co Ltd (2015–2025)
Total liabilities of Kodi-M Co Ltd from 2015 to 2025. This chart illustrates how Kodi-M Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 224060 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Kodi-M Co Ltd Competitors by Total Liabilities
The table below lists competitors of Kodi-M Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Seacera Group Bhd
KLSE:7073
|
Malaysia | RM130.81 Million |
|
Micronet Ltd
TA:MCRNT
|
Israel | ILA612.00K |
|
In8bio Inc
NASDAQ:INAB
|
USA | $3.38 Million |
|
Praxis Home Retail Limited
NSE:PRAXIS
|
India | Rs2.60 Billion |
|
Eastern International Ltd.
NASDAQ:ELOG
|
USA | $17.09 Million |
|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
USA | $3.20 Million |
|
TEN Holdings, Inc. Common Stock
NASDAQ:XHLD
|
USA | $3.07 Million |
|
Pergamon Status Dis Ticaret AS
IS:PSDTC
|
Turkey | TL4.93 Billion |
Liability Composition Analysis (2015–2025)
This chart breaks down Kodi-M Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Kodi-M Co Ltd total assets.
Liquidity & Leverage Metrics
Kodi-M Co Ltd Total Liabilities Ratios Explained
Kodi-M Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.59 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.94 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Kodi-M Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Kodi-M Co Ltd (2015–2025)
The table below shows the annual total liabilities of Kodi-M Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩61.56 Billion ≈ $41.72 Million |
+26.00% |
| 2024-12-31 | ₩48.86 Billion ≈ $33.11 Million |
-27.32% |
| 2023-12-31 | ₩67.22 Billion ≈ $45.56 Million |
+44.04% |
| 2022-12-31 | ₩46.67 Billion ≈ $31.63 Million |
-30.14% |
| 2021-12-31 | ₩66.80 Billion ≈ $45.27 Million |
+48.12% |
| 2020-12-31 | ₩45.10 Billion ≈ $30.56 Million |
-12.47% |
| 2019-12-31 | ₩51.52 Billion ≈ $34.92 Million |
+36.97% |
| 2018-12-31 | ₩37.62 Billion ≈ $25.49 Million |
+561.81% |
| 2017-12-31 | ₩5.68 Billion ≈ $3.85 Million |
-89.14% |
| 2016-12-31 | ₩52.34 Billion ≈ $35.47 Million |
+570.96% |
| 2015-12-31 | ₩7.80 Billion ≈ $5.29 Million |
-- |
About Kodi-M Co Ltd
THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and chang… Read more